The decrement in circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia
Diabetes/Metabolism Research and Reviews2010Vol. 27(2), pp. 185–194
Citations Over Time
Mingfang Li, Jenny C. Y. Ho, Kevin Lai, Karen K. W. Au, Aimin Xu, Bernard M.Y. Cheung, Karen S.L. Lam, Hung‐Fat Tse
Abstract
We detected no relationship between the reduction in the level of EPC and in the level of total adiponectin in blood from patients with type 2 diabetes. EPC from patients with diabetes were stimulated when exposed to adiponectin in the test tube, findings that warrant further study.
Related Papers
- → Circulating Hematopoietic Progenitor Cells are Decreased in COPD(2013)27 cited
- → Regular Exercise Training Increases the Number of Endothelial Progenitor Cells and Decreases Homocysteine Levels in Healthy Peripheral Blood(2014)24 cited
- → A flow cytometric approach to analyzing mature and progenitor endothelial cells following traumatic brain injury(2016)13 cited
- → Detrimental Impact of Low Birth Weight on Circulating Number and Functional Capacity of Endothelial Progenitor Cells in Healthy Children: Role of Angiogenic Factors(2019)16 cited
- → Differential MMP-9 activity in CD34+progenitor cell-derived foam cells from diabetic and normoglycemic patients(2013)